Studien

Die Ärzte des AURELIOS Augenzentrum sind regelmäßig sowohl Initiatoren als auch Teilnehmer an nationalen und internationalen Studien zu verschiedenen Themen.

• The Hydrus™ Aqueus Implant Trial: A prospective, multi-center evaluation oft he hydrus aqueus implant (standard and low-profile) for lowering intraocular pressure (IOP) in subjects with mild to moderate primary open angle glaucoma (POAG) with or without a cataract; Protokoll-Nr.: CP-09-001-A; Beginn: Januar 2010.
• A 12-month, two armed, randomized, double-masked, multicentre, Phase IIIb study assessing the efficancy and safety of laser photocoagulation as adjunctive to Ranibizumab intravitreal injections vs. laser photocoagulation monotherapy in patients with visual impairment due to diabetic macular edema followed by a 12 month follow up period
  Studien-Code: CRFB002DDE13; EudraCT-Nummer: 2010-018852-29; Projekt Nummer: RFB002D
• 6-month Multicenter, Randomized, Double-masked Phase IIIb-study Comparing the Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Visual Impairment Due to Macular Edema Following Branch Retinal Vein Occlusion (BRVO), Studien-Code: CRFB002EDE17
• A 6-month Multicenter, Randomized, Double-masked Phase IIIb-study Comparing the Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Visual Impairment Due to Macular Edema Following Central Retinal Vein Occlusion (CRVO), Studien-Code: CRFB002EDE18